PerkinElmer shuffles execs

PerkinElmer has appointed its president and CEO, Robert Friel, as chairman of the board of directors; in addition, Frank A. Wilson, was named senior vice president, chief financial officer and chief accounting officer.

The announcement was made at the company's April 28 annual shareholders meeting, according to the Waltham, Mass.-based company. Friel succeeds Gregory Summe, chairman since 1999, who did not stand for re-election. Friel joined PerkinElmer in 1999 as CFO and was appointed vice chairman and president of the company's life and analytical sciences business in 2006. In 2007, Friel was appointed president and chief operating officer of the company. He succeeded Summe as CEO in 2008.

In his new role, Wilson will have overall leadership responsibility for the strategy and operations for all of the company's finance and control functions. He will assume his new role on May 18. Previously, Wilson was the corporate VP of investor relations at Danaher, a manufacturer of professional instrumentation, medical and industrial technologies and tools and components. While at Danaher, he held financial and business management roles. Wilson joined Danaher in 1997, after several years with AlliedSignal (now Honeywell International) where he served as CFO for one of its businesses. His prior experience includes five years with PepsiCo in financial leadership and controllership positions and five years with KPMG Peat Marwick.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.